Between 1988 and 2017, there were significant global variations and trends in ovarian cancer incidence and its subtypes, ...

whereas 10% are non-epithelial ovarian cancers, including sex cord-stromal and germ cell tumors. In the current study, researchers assess global patterns and trends in the incidence and ...

3, 2025 — Tumor cells circulating in the blood are the 'germ cells' of breast cancer metastases ... Imaging Technique Allows Rapid Assessment of Ovarian Cancer Subtypes and Their Response ...

Accumulating evidence indicates that epigenetic modifiers have key roles in genome-wide reprogramming and activation and repression of specific genes during mammalian germ-cell development.

Cabometyx is under clinical development by Exelixis and currently in Phase II for Salivary Gland Cancer. According to GlobalData, Phase II drugs for Salivary Gland Cancer have a 14% phase transition ...

Our center emphasizes personalized care for people with uterine sarcomas, low-grade serous ovarian carcinoma, uterine serous carcinoma, clear cell and mucinous tumors of the ovary, germ cell and sex ...

Durvalumab is under clinical development by AstraZeneca and currently in Phase II for Salivary Gland Cancer. According to GlobalData, Phase II drugs for Salivary Gland Cancer have a 14% phase ...

These diseases all involve the development of germ cells, the structure and function of reproductive ... expression caused by abnormal development of reproductive organs, gonadal (ovarian or ...

To address this gap, researchers analyzed gene expression within individual tumor cells. This study reports the molecular features and interactions of tumor and immune cells associated with two ...

As part of the partnership, the charity also delivered its life-saving awareness talk around testicular and ovarian cancer to staff ... to raise awareness of germ cell cancers and also provide ...